Estrogen-related receptor α (ERRα) is a key regulator of mitochondrial function and metabolism essential for energy-driven cellular processes in both normal and cancer cells. ERRα has also been shown to mediate bone-derived macrophage activation by proinflammatory cytokines. However, the role of ERRα in cancer in which inflammation acts as a tumor promoter has yet to be investigated. Herein we show that global loss of ERRα accelerates the development of diethylnitrosamine (DEN)-induced hepatocellular carcinoma. Biochemical and metabolomics studies revealed that loss of ERRα promotes hepatocyte necrosis over apoptosis in response to DEN due to a deficiency in energy production. We further show that increased hepatocyte death and associated compensatory proliferation observed in DEN-injured ERRα-null livers is concomitant with increased nuclear factor κB (NF-κB)-dependent transcriptional control of cytokine expression in Kupffer cells. In particular, we demonstrate that loss of ERRα-dependent regulation of the NF-κB inhibitor IκBα leads to enhanced NF-κB activity and cytokine gene activation. Our work thus shows that global loss of ERRα activity promotes hepatocellular carcinoma by independent but synergistic mechanisms in hepatocytes and Kupffer cells, implying that pharmacological manipulation of ERRα activity may have a significant clinical impact on carcinogen-induced cancers. nuclear receptor | liver cancer H epatocellular carcinoma (HCC) is a major cause of cancer deaths worldwide, particularly in countries with high risk factors that include greater exposure to aflatoxin B1, a fungal contaminant in dietary supplies, and to the hepatitis B and C viruses (1). HCC has also been linked with exposure to toxic chemicals such as polycyclic aromatic hydrocarbons and nitrosamines and is more frequent in individuals with cirrhosis associated with chronic inflammation (2, 3). HCC that closely resembles the human disease can be induced in mice with a single postnatal injection of the tumor initiator diethylnitrosamine (DEN) (4). In this model, DNA damage induced by the carcinogen promotes cell death, which leads to an inflammatory response by resident Kupffer cells that further stimulates tumor development fueled by compensatory proliferation of hepatocytes (5). It has been shown that nuclear factor κB (NF-κB) signaling, a critical intracellular pathway in the regulation of inflammation, plays a complex role in DEN-induced hepatocarcinogenesis, displaying antitumorigenic and procarcinogenic activity in hepatocytes and Kupffer cells, respectively. In hepatocytes, NF-κB signaling protects against cell death, thus attenuating compensatory cell proliferation, while promoting the inflammatory response of Kupffer cells and production of hepatomitogens (5).
H epatocellular carcinoma (HCC) is a major cause of cancer deaths worldwide, particularly in countries with high risk factors that include greater exposure to aflatoxin B1, a fungal contaminant in dietary supplies, and to the hepatitis B and C viruses (1) . HCC has also been linked with exposure to toxic chemicals such as polycyclic aromatic hydrocarbons and nitrosamines and is more frequent in individuals with cirrhosis associated with chronic inflammation (2, 3) . HCC that closely resembles the human disease can be induced in mice with a single postnatal injection of the tumor initiator diethylnitrosamine (DEN) (4) . In this model, DNA damage induced by the carcinogen promotes cell death, which leads to an inflammatory response by resident Kupffer cells that further stimulates tumor development fueled by compensatory proliferation of hepatocytes (5) . It has been shown that nuclear factor κB (NF-κB) signaling, a critical intracellular pathway in the regulation of inflammation, plays a complex role in DEN-induced hepatocarcinogenesis, displaying antitumorigenic and procarcinogenic activity in hepatocytes and Kupffer cells, respectively. In hepatocytes, NF-κB signaling protects against cell death, thus attenuating compensatory cell proliferation, while promoting the inflammatory response of Kupffer cells and production of hepatomitogens (5) .
Estrogen-related receptor α (ERRα) is an orphan nuclear receptor that plays a central role in the control of energy metabolism (6) . As a transcription factor, ERRα directly regulates the expression of genes required for mitochondrial biogenesis and function, including genes encoding enzymes and proteins participating in the tricarboxylic acid (TCA) cycle, pyruvate metabolism, oxidative phosphorylation, and electron transport (7) (8) (9) (10) (11) . Extensive phenotypic analyses of the ERRα-null mouse model have shown that ERRα specifies the energetic properties required for cell-and tissue-specific functions (12) . In bonederived macrophages, the expression of ERRα is stimulated by proinflammatory cytokines, and the presence of ERRα is required for efficient mitochondrial respiratory activities, production of reactive oxygen species (ROS), and pathogen clearance (13) . In the liver, pharmacological or genetic inhibition of ERRα activity alters the expression profile of genes involved in the TCA cycle and lipid biogenesis, stimulates the accumulation of TCA cycle metabolites, and exacerbates hepatic hyperlipidemia induced by the anticancer drug rapamycin (11) . ERRα also influences the proliferation of cancer cells by promoting a metabolic shift favoring the use of glucose as an energy source, a phenomenon referred to as the Warburg effect, and by regulating the expression of key oncogenes (14) (15) (16) (17) .
The link between ERRα as a regulator of energy metabolism, its role in inflammatory processes, and its role as a facilitator of cancer cell growth raised the question of whether ERRα also plays a role in inflammation-associated cancers. In this study, we examined the development of DEN-induced HCC in ERRα-null mice. Unexpectedly, our study reveals that loss of ERRα accelerates the progression of DEN-induced HCC despite reduced ROS levels and mitochondrial dysfunction in hepatocytes. Loss of ERRα impaired the DEN-stimulated energy-dependent apoptotic ability of hepatocytes but increased liver damage through Significance This study shows that absence of the orphan nuclear receptor estrogen-related receptor α (ERRα), a master regulator of cellular energy metabolism, predisposes mice to hepatocellular cancer development when exposed to a known carcinogen. Biochemical and metabolomics studies revealed that loss of ERRα promotes hepatocyte necrosis over apoptosis in response to a carcinogen due to a deficiency in energy production. In addition, we demonstrate that loss of ERRα-dependent regulation of the nuclear factor κB (NF-κB) inhibitor IκBα leads to enhanced NF-κB activity and cytokine gene activation. These findings have particular biological significance in view that rapamycin, a drug currently in use in various clinical settings, has been shown recently to decrease ERRα protein levels and activity in mouse liver.
necrotic cell death. On the other hand, DEN treatment led to a greater activation of the NF-κB pathway in the absence of ERRα in Kupffer cells, resulting in an increase in the inflammatory response and production of hepatomitogens, thereby augmenting compensatory proliferation of hepatocytes. Our work thus uncovers an important protective role for ERRα against inflammatory-related cancers and further highlights the complexity of ERRα action in the oncogenic process.
Results
Loss of ERRα Promotes DEN-Induced HCC. To investigate the role of ERRα in HCC development, 14-d-old wild-type (WT) and ERRα knockout (KO) male mice were injected with a single dose of the carcinogen DEN. Absence of ERRα significantly enhanced HCC development in response to DEN compared with WT mice (Table S1 ). Representative images of DEN-treated 9-mo-old livers show accelerated HCC development in ERRα-null mice characterized by an increase in the number of tumor nodules (Fig. 1A) . At 9 mo of age, HCC was observed in all DEN-treated ERRα-null mice compared with only 25% in the DEN-treated WT mice (Fig. 1B and Table S1 ). At this time point, ERRα-null livers were found to have approximately five times more tumors corresponding to higher liver weights compared with WT in response to DEN ( Fig. 1 C and D) . Moreover, DEN treatment resulted in greater liver injury in mice lacking ERRα relative to WT as demonstrated by a significantly higher level of serum alanine aminotransferase (ALT) in these mice (Fig. 1E ). Histological examination of 9-mo-old livers of DEN-treated WT and ERRα-null mice is shown in Fig. 1F . K i -67 labeling revealed significantly elevated levels of cell proliferation in the HCC region of livers lacking ERRα but not in the normal parenchyma (Fig. 1G) . The increased tumor burden observed in DEN-treated ERRα KO mice also led to a significant decrease in survival of these mice compared with similarly treated WT mice (Fig. 1H ).
DEN-Induced Hepatic Injury and Decreased Mitochondrial Function in
ERRα-Null Hepatocytes. To further investigate the mechanisms underlying the protective action of ERRα in DEN-induced HCC before tumor formation, 6-wk-old WT and ERRα-null mice were subjected to a short-term exposure of a high dose of DEN. In agreement with the phenotype observed in the long-term DEN exposure experiment, mice lacking ERRα were found to exhibit significantly greater DEN-induced hepatic injury 48 h posttreatment as determined by increased serum ALT levels ( Fig.  2A ) and tumor protein p53 (p53) stabilization (Fig. 2B) . The rise in p53 levels was accompanied by an increase in transcript levels of the p53-dependent proapoptotic genes Bax and Pmaip1 (also known as NOXA) (Fig. 2C) . We next explored whether ablation of ERRα affected mitochondrial function and ROS production. The expression of key ERRα nuclear-encoded mitochondrial target genes (Mdh2, Sdhd, Cycs, and Cox5b) were all significantly decreased in ERRα-null livers, a reduction that is independent of DEN treatment (Fig. 2D ). As expected, DEN treatment led to a general increase in ROS abundance in WT livers (Fig. 2E) . In contrast, the induction of ROS levels in response to DEN was blunted in livers lacking ERRα (Fig. 2E ). This observation indicates that the greater DEN-driven liver injury observed in ERRα-null mice is not mediated by an increase in ROS-mediated tissue damage.
The reduction in ROS levels observed in ERRα-null livers indicates potential mitochondrial dysfunction. We next used cultured primary hepatocytes derived from WT and ERRα-null mice to further determine whether the loss of ERRα leads to altered metabolic energy production and mitochondrial biogenesis. Metabolomics analyses revealed significantly decreased phosphocreatine (PCre) levels associated with a more than twofold increase in the AMP/ATP ratio in ERRα-null hepatocytes compared with WT cells (Fig. 3 A and B) . Moreover, hepatocytes lacking ERRα have increased mitochondrial biogenesis characterized by a higher proportion of mitochondrial DNA versus genomic DNA compared with control cells (Fig.  3C) . The data show that in the absence of ERRα, liver cells have decreased energy production due to impaired mitochondrial function, an observation that is validated by the increase in mitochondrial content to compensate for their inefficiency. The relationship between ERRα activity and cellular energy production was further investigated by treating WT and ERRα-null primary hepatocytes with tumor necrosis factor α (TNFα), an inflammatory cytokine known to induce inflammation-associated apoptotic cell death and ATP synthesis (18) . TNFα treatment resulted in a robust increase in ATP production in WT hepatocytes associated with a decrease in the AMP/ATP ratio ( Fig. 3 D and E). Strikingly, TNFα failed to induce energy production ( Fig. 3D ) or affect the AMP/ATP ratio ( Fig. 3E ) in ERRα-null primary hepatocytes.
Loss of ERRα Enhances Hepatocellular Necrosis. Increased hepatocyte cell death was observed in mice lacking ERRα in response to DEN as determined by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) assays ( Fig. S1 A and B). We then examined whether the increased cell death exhibited in DEN-injured livers of ERRα-null mice involved apoptosis. Although both genotypes were found to have similar hepatic protein levels of the intact caspases 3, 6, and 9, ERRα-null livers had significantly less cleaved caspase 3 levels following DEN injection (Fig. 4 A and B) . The data suggest that the DENinduced hepatic cell death observed in mice lacking ERRα occurs predominantly via necrosis rather than by apoptosis, an energyconsuming process (19) . Indeed, TNFα induction of apoptotic cell death was only observed in WT hepatocytes as demonstrated by the presence of cleaved caspase 3 in these cells but not in ERRα-null hepatocytes ( Fig. 4 C and D) . The data suggest that TNFα-mediated cell death in ERRα-null hepatocytes likely occurs via necrosis, a non-energy-requiring process. To test this hypothesis, we next evaluated the influence of ERRα activity on the cellular release of the high-mobility group box 1 (HMGB1) protein. HMGB1 is specifically released by necrotic cells and used as a marker to distinguish between necrotic and apoptotic cell death (20) . As WT and ERRα-null primary hepatocytes are cultured in media invariably contaminated by HMGB1 release from cells dying spontaneously, it is not reliable to measure TNFα-induced cell death in this system. To circumvent this problem, the release of HMGB1 was studied using the murine cell line Hepa 1-6 treated with or without compound 29 (C29), a highly specific ERRα inverse agonist (21) , and/or CoCl 2 , a chemical known to induce apoptosis (22) . Treatment of cells with C29 alone resulted in loss of ERRα protein and release of HMGB1 in the media (Fig. 4E ). Pharmacological inhibition of ERRα by C29 also suppressed CoCl 2 -mediated apoptotic cell death as demonstrated by the loss of caspase 3 cleavage and again promoted the release of HMGB1 in the media (Fig. 4E ).
Like WT Hepa 1-6 cells, cells overexpressing ERRα resulted in CoCl 2 -dependent apoptotic cell death (Fig. 4F) . Taken together, the data suggest that loss of ERRα decreases mitochondrial energy production, which results in a reduced ability of the cells to undergo ATP-dependent apoptosis. Thus, ERRα-null hepatocytes are more likely to die by necrosis upon receiving the chemical insult of DEN.
ERRα-Null Mice Exhibit Increased NF-κB-Dependent Cytokine-Driven
Compensatory Hepatocyte Proliferation in Response to DEN. As loss of ERRα results in increased DEN-induced liver damage and hepatocellular death by necrosis, a phenomenon that would cause release of cellular constituents and activation of Kupffer cells, we next investigated a potential role for ERRα in cytokine-driven compensatory proliferation. First, the level of DNA synthesis as an indicator of cell proliferation was assessed by 5-bromo-2′-deoxyuridine (BrdU) labeling of livers acutely exposed to DEN. In agreement with the enhanced level of DEN-stimulated proliferation observed in 9-mo-old HCC-bearing mice ( Fig.  1F ), acute DEN treatment resulted in enhanced proliferation in ERRα-null livers 48 h posttreatment compared with DEN-treated WT mice (Fig. 5A ). In response to acute DEN treatment, mice lacking ERRα, compared with WT mice, were also found to have significantly elevated hepatic expression levels of the genes Il1a, Il6, Tnf, and Hgf encoding the proinflammatory cytokines interleukin (IL)-1α, IL-6, TNFα, and hepatocyte growth factor (HGF), respectively ( Fig. 5B ). Note that HGF originates from stellate cells, whereas IL-1α, IL-6, and TNFα are produced by Kupffer cells. Moreover, mice lacking ERRα were found to have increased serum levels of both IL-1α and HGF in response to a 48-h DEN treatment (Fig. S2) . Similarly, the endotoxin lipopolysaccharide (LPS) led to a greater induction in cytokine expression in isolated ERRα-null Kupffer cells compared with WT resident macrophages (Fig. 5C ). Livers of DEN-treated ERRα-null mice were found to have higher nuclear levels of both NF-κB subunits p50 and p65 (Fig. 5D ). This observation suggests that the increased DEN-induced cytokine-associated compensatory proliferation observed in ERRα-null livers may result in an intensification of NF-κB activity in these cells. A recent ChIPsequencing (ChIP-seq) study identified NF-κB binding events in the regulatory regions of these differentially regulated cytokines (23) . We thus tested whether livers of DEN-treated mice lacking ERRα display increased recruitment of p65 to the NF-κB response elements present in these cytokine genes. As shown in Fig.  5E and Fig. S3A , binding of p65 to these sites was significantly augmented in DEN-treated ERRα-null livers. The data imply that ERRα may act as a repressor of NF-κB signaling. Analysis of our recent mouse liver ERRα ChIP-seq study (11) revealed that the gene Nfkbia, which encodes the NF-κB suppressor IκBα, is a direct transcriptional target of ERRα. IκBα acts as an inhibitor of NF-κB signaling by sequestering NF-κB dimers in the cytoplasm, thereby preventing NF-κB-dependent transcriptional activity (24) . ERRα ChIP experiments in both mouse liver and the macrophage cell line Raw 264.7 validate that ERRα is indeed recruited to the gene Nfkbia at a regulatory region containing the consensus ERR response element, TCAAGGTCA ( Fig.  5F and Fig. S3B ). Decreased expression of Nfkbia was found in both ERRα-null liver extracts and isolated primary Kupffer cells compared with control ( Fig. S4 A and B) . In addition, treatment of Raw 264.7 cells with the ERRα inverse agonists C29 and XCT790 or a vector expressing ERRα resulted in decreased or increased IκBα transcript and protein levels, respectively (Fig.  S4 C-E and Fig. 5 G-I) . Moreover, livers of WT and ERRα-null mice subjected to an acute DEN treatment show reduced Nfkbia mRNA and protein levels ( Fig. 5 J and K, respectively) . Taken together, the data identify ERRα as a direct repressor of NF-κB signaling.
Discussion
It is well-established that inflammatory-related diseases increase the risk of various types of cancer including liver, colon, gastric, ovarian, and prostate cancer (25) (26) (27) (28) (29) . Chronic inflammation is an important element of HCC development and progression and is associated with proliferation, angiogenesis, and metastasis (26) . In addition, there is a clear connection between metabolic dysfunction and the immune response (30, 31) . The generation and utilization of energy is a key process during inflammation, and given the known function of ERRα as a global regulator of energy metabolism (6) and its importance in pathogen resistance (13) and in various types of cancer (32), we sought to investigate the role of ERRα in inflammation-related HCC development. Our work revealed that ERRα-null mice have an increased susceptibility to HCC initiation and progression. We show that loss of ERRα results in increased incidence and hepatic tumor number compared with WT mice following administration of DEN, a known carcinogen, resulting in premature lethality. Furthermore, DEN was found to induce greater liver damage assessed by circulating ALT levels and p53 function accompanied by increased hepatocellular death in ERRα-null mice. Although DEN has been shown to induce liver injury and hepatocyte cell death via ROS accumulation (33), we observed an inverse relationship between ALT and ROS levels in mice lacking ERRα in response to DEN. These results indicate that the liver damage in these mice is not predominantly mediated by intracellular ROS levels and that the lack of ROS may interfere with proper defense mechanisms against tumorigenesis such as apoptosis. Impaired ROS production in the absence of ERRα has also been previously observed in ERRα-null macrophages treated with the proinflammatory cytokine, IFN-γ, leading to a weakened response of bone-derived macrophages to pathogenic insults (13) . However, in the context of HCC, loss of ERRα was found to enhance the inflammation-driven compensatory proliferation in response to increased DEN-stimulated cell death.
In vivo and in vitro studies provide evidence that the DENinduced cell death in ERRα-null mice occurs via necrosis in contrast to ATP-dependent apoptosis. As previously observed, mice lacking ERRα were found to display decreased hepatic transcript levels of ERRα mitochondrial target genes (7, 9, 11) . The mitochondrial dysfunction exhibited in ERRα-null mice was associated with decreased hepatic PCre energy reserves and increased AMP/ATP ratio. The results are in accordance with the decreased energy supply found in hearts of mice lacking ERRα (34) . TNFα-induced cell death in WT primary hepatocytes enhanced ATP production required to undergo caspase-dependent apoptotic cell death, a process that was lost in ERRα-null hepatocytes. Our data show that in contrast to cells overexpressing ERRα, cells lacking ERRα activity mediate chemically induced cell death primarily via necrosis, a non-energy-demanding process, rather than ATP-dependent apoptosis. These findings are particularly interesting in light of reports that tumor growth stimulated by necrotic death is mediated by compensatory proliferation (5) and that approaches to treat cancer by increasing apoptotic cell death and/or suppressing necrosis in tumors are studied (35) .
Increased cell death observed in livers of DEN-injured ERRα-null mice was accompanied by enhanced compensatory proliferation. Activation of NF-κB signaling is a hallmark of various inflammatory-related diseases and inflammation-associated cancers (36) . NF-κB signaling is activated by various stimuli including cytokines and necrotic effectors to mediate an inflammatory response. We provide evidence for a role of ERRα as a direct positive regulator of the NF-κB inhibitor, IκBα, capable of sequestering NF-κB in the cytoplasm. Inhibition or activation of ERRα in macrophage cells results in decreased or increased transcript and protein levels of IκBα. In vivo, we demonstrate that loss of ERRα results in enhanced hepatic NF-κB nuclear translocation. Consequently, we observed increased transcript levels of NF-κB proinflammatory cytokine targets including IL-1α, IL-6, TNFα, and HGF in livers of DEN-treated mice lacking ERRα. IL-1α has been previously linked to necrotic cell death (33) , and DEN-induced IL-6 production has been shown to lead to a liver regenerative response through hepatocyte proliferation (37) . In addition, IL-6 has been found to prevent apoptosis by inducing Bcl-2 and Bcl2l1 (Bcl-xl) levels (38, 39) . The genes encoding these two apoptotic regulators were found to be significantly up-regulated in livers of ERRα-null mice in response to acute DEN treatment (Fig. S5 ). In addition, previous studies have demonstrated that TNFα can mediate a hepatocyte damage response via JNK activation (40, 41) . Moreover, the growth factor HGF secreted from stellate cells is known to promote DNA synthesis and hepatocyte proliferation during liver regeneration following injury (42) . Furthermore, a greater induction in NF-κB cytokine target gene expression was observed in LPS-treated Kupffer cells lacking ERRα compared with WT-treated cells. Our findings thus identify a previously unknown molecular crosstalk between ERRα and NF-κB signaling.
The increased susceptibility to DEN-induced HCC initiation and progression in mice lacking ERRα is remarkable given that they exhibit impaired mitochondrial function. Results presented in our report indicate that the accelerated development of DENinduced HCC in ERRα-null mice involves increased cytokine production as a consequence of hepatocyte necrotic death and compensatory proliferation due to the loss of ERRα repression of NF-κB signaling in macrophages. These findings have particular biological significance in view that rapamycin, an mTOR inhibitor currently in use in various clinical settings, has been shown recently to decrease ERRα protein levels and activity in mouse liver (11) . In addition, molecules such as C29, a selective and bioavailable ERRα inhibitor, are being developed for the treatment of metabolic disorders including obesity and diabetes (21) . This study thus indicates that positive modulation of ERRα activity could be envisioned to treat inflammatory-related diseases and cancer.
Methods
Animals. WT and ERRα KO mice (43) in a C57BL/6J background were housed in a pathogen-free facility at McGill University and fed standard chow with water provided ad libitum. All mouse experiments were approved and performed in accordance with the McGill Facility Animal Care Committee and the Canadian Council on Animal Care. For hepatocarcinogenesis experiments, 14-d-old mice were administered DEN (25 mg/kg body weight; N0258; Sigma) in a 0.9% saline solution by i.p. injection. The animals were monitored thereafter by palpation for tumor formation and killed by cervical dislocation at the indicated time points for serum and liver isolation. For acute DEN experiments, 6-wk-old mice were administered DEN (100 mg/kg body weight) in a 0.9% saline solution by i.p. injection, and livers were isolated at the indicated time points following injection. For the assessment of in vivo hepatocyte proliferation following acute DEN treatment, mice were injected with BrdU (1 mg per mouse; B5002; Sigma) 2 h before they were killed.
Cell Culture. All cell culture reagents were from Life Technologies. The Raw 264.7 murine macrophage cell line, Hepa 1-6 murine hepatoma cell line, and primary WT and ERRα-null hepatocytes and Kupffer cells were maintained at 37°C in a 5% CO 2 atmosphere in DMEM supplemented with 10% (vol/vol) FBS, penicillin (100 U/mol), and streptomycin (100 μg/mL). Raw 264.7 cells ) were plated in 6-cm plates with media containing 2% FBS, and the next day the cells were transfected with either 7 μg of empty vector [cytomegalovirus-based expression plasmid (CMX)] or CMX-mERRα using FuGENE HD transfection reagent (FuGENE HD:DNA ratio = 3.5:1; E2311; Promega) and were harvested 48 h later. Hepa 1-6 cells were treated daily over a 3-d period with either vehicle (DMSO) or 10 μM compound 29 in the presence or absence of 100 μM cobalt chloride (CoCl 2 ; 202185; Sigma). For overexpression studies, Hepa 1-6 cells were transfected with either empty vector (CMX) or CMX-mERRα using HiPerFect reagent (Qiagen) and treated with or without 100 μM CoCl 2 for 2 d. Primary hepatocytes isolated and cultured from WT and ERRα KO mice were treated with vehicle (PBS) or 10 ng/mL TNFα (410-TRNC-010; R&D Systems) for 3 h. Primary Kupffer cells isolated and cultured from WT and ERRα KO mice were treated for 3 h with either vehicle (PBS) or 10 ng/mL LPS (L3012; Sigma). Briefly, mice were anesthetized, and the peritoneal cavity was opened. Livers were perfused with Ca 2+ and Mg 2+ free-HBSS containing EDTA (1 mM) and then digested with a collagenase solution containing liberase thermolysin medium research grade (0.1 mg/mL; 01 401 119 001; Roche), glucose (1%), CaCl 2 (5 mM), and DNase I (10 μg/mL) in HBSS. Digested livers were removed and rinsed twice with HBSS and then gently teased with forceps until they were in solution. The cell suspensions were filtered through a sterile 100-μm nylon cell strainer (BD Biosciences) to remove undigested tissue and connective tissue. The cells were centrifuged for 5 min at 650 × g and resuspended with HBSS. After the cell suspensions were centrifuged for 3 min at 35 × g, the supernatants (nonparenchymal cells such as Kupffer cells) were transferred to a new tube, and the pellets (parenchymal cells such as hepatocytes) were resuspended with HBSS.
For Kupffer cell isolation, the supernatants obtained as described above were centrifuged using a two-step Percoll gradient [25%/50% (vol/vol)] for 15 min at 1,800 × g with the brake option off. Subsequently, the upper layers were removed, and the middle layers between 25% and 50% Percoll gradient were collected without contamination from the pellets. The collected middle layers were washed twice with DMEM supplemented with 10% (vol/vol) FBS then plated into six-well tissue culture plates. One hour following seeding, nonadherent cells (cell debris or blood cells) were removed by aspiration, and fresh media was added. After 24 h, the cells were treated with 0.5% trypsin-0.02% EDTA to remove endothelial cells, and the attached Kupffer cells were cultured for another 24 h, at which time they were ready for experimental use.
For hepatocyte isolation, the pellet suspensions obtained as described above were centrifuged using 50% Percoll for 15 min at 1,800 × g with the brake option off. After centrifugation, the healthy hepatocytes were pelleted as damaged hepatocytes, or nonparenchymal cells could not penetrate into 50% Percoll solution. The pellets were washed twice with DMEM supplemented with 10% FBS, and then 5 × 10 5 hepatocytes were seeded into sixwell tissue culture plates. After 24 h, nonadherent cells were removed by aspiration, and fresh media was added.
ALT Measurements. Mouse blood samples were transferred into 1.1 mL Z-Gel microcentrifuge tubes containing a serum-gel clotting activator (41.1378.005; Sarstedt). The samples were allowed to clot for 30 min at room temperature before centrifugation for 30 min at 2,348 × g. Serum samples were removed without disturbing the gel layers. Alanine aminotransferase (ALT) levels were determined using the International Federation of Clinical Chemistry comparative method at the diagnostic laboratory of the Comparative Medicine Animal Resource Centre at McGill University.
Microsomal Reactive Oxygen Species Measurements. Whole livers from diethylnitrosamine (DEN)-induced acute liver injury were homogenized with lysis buffer (0.25 M sucrose, 5 mM Hepes, 1 mM EDTA pH 7.2). The homogenates were centrifuged at 500 × g for 10 min at 4°C, and the supernatants were transferred into new tubes and centrifuged for 10 min at 9,500 × g. After centrifugation, the supernatants were removed by aspiration, and the pellets were resuspended in ice-cold PBS containing 20 mM glucose. The microsomal proteins were quantified using the Micro bicinchoninic acid (BCA) Protein Assay kit (PI23235; Thermo Scientific). Liver microsomes (0.05 mg) were incubated in the dark at 37°C in PBS containing 10 μM 2',7'-dichlorodihydrofluoresceine diacetate (H 2 DCFDA; D399; Life Technologies) for 1 h in a 96-well black plate. The levels of reactive oxygen species were detected by measurement of the fluorescent product using a fluorescence microplate reader (excitation, 485 nm; emission, 528 nm).
ELISA. Circulating IL-1α and HGF levels were detected in serum from WT and ERRα-null mice acutely treated with DEN for the indicated time points. ELISA kits were obtained from R&D Systems (MLA00 for IL-1α and MHG00 for HGF).
Histological and Immunohistological Analyses. For histological analyses, livers were fixed in 10% buffered formalin for 48 h and subsequently paraffin-embedded. Serial sections were stained with Hematoxylin and Eosin, and stained slides were examined using an Aperio XT Slide Scanner (Aperio). For BrdU detection (550803; BD Bioscience) the tissue sections were incubated with 0.1 M citrate buffer (pH 6.0) at 95-100°C for 1 h. After blocking with 10% normal donkey serum, slides were incubated with primary antibodies [cleaved caspase 3 (9664; Cell Signaling) and Tubulin] at 4°C overnight. Following this, slides were washed and incubated simultaneously with the corresponding AlexaFluor conjugated secondary antibodies from Life Technologies diluted in TBS with 1% donkey serum at room temperature for 1 h. After washing, slides were mounted in ProLong Gold antifade reagent (P36931; Invitrogen) and examined using an Axioskop microscope (Zeiss). For immune-reactive K i -67 (ab15580; Abcam) and cell death (11 684 812 910; Roche) in situ, paraffinembedded tissue sections were dewaxed and rehydrated. Cell death analysis was done using the In Situ Cell Death Detection Kit as per the manufacturer's specifications. For immune-reactive K i -67 assay, the tissue sections were incubated with blocking buffer (1% BSA in PBS) at 37°C for 1 h. Slides were then incubated with primary antibodies (1:200) at room temperature for 1 h, washed in PBS, and incubated with the corresponding AlexaFluor conjugated secondary antibody. After washing, slides were mounted in ProLong Gold antifade. Proliferation was assessed by the percentage of K i -67-positive cells. Histology experiments were performed in collaboration with the Goodman Cancer Research Centre Histology Core Facility.
Primary hepatocytes were grown in standard culture medium as described above and cultured in eight-well chambers on tissue culture glass slides (BD Bioscience). The cells were washed in PBS and fixed in 100% methanol at −20°C for 20 min. Slides were air-dried and then rehydrated in PBS. The fixed cells were blocked with 10% goat serum at room temperature for 30 min and incubated overnight with primary antibodies at 4°C. Following this, slides were washed and incubated with Alexa-Fluor conjugated secondary antibodies (Life Technologies) diluted 1:1,000 in PBS containing 1% normal goat serum at room temperature for 1 h. After washing, slides were mounted in ProLong Gold antifade reagent and examined using an Axioskop microscope (Zeiss).
ChIP. Mouse liver ChIP samples were prepared from 2-to 3-moold male mice treated with or without DEN (100 mg/kg) for 48 h. Briefly, livers were isolated, weighed, and homogenized for a few seconds (until no tissue clumps) in cold PBS using a Brinkmann polytron homogenizer. The samples were centrifuged at 1,721 × g for 2 min at 4°C, and the cell pellets were resuspended in cold PBS. Following centrifugation, the pellets were resuspended in PBS containing formaldehyde (1% final), and DNA-protein cross-linking was allowed to occur at room temperature for 10 min with rotation. Samples were then centrifuged at 1,721 × g for 2 min at 4°C, and the pellets were washed twice with cold PBS and resuspended in nuclei lysis buffer (50 mM Tris·HCl, pH 8.1, 10 mM EDTA, 1% SDS) supplemented with protease inhibitors (Roche). Samples were sonicated on ice at power 10 for 30-s pulses using a VirSonic 100 (Virtis) sonicator at 30-s intervals to prevent the samples from heating. Sonicated material was centrifuged at 15,871 × g for 15 min at 4°C to remove cellular debris and chromatin (100 μg) was diluted in 2.5× ChIP dilution buffer (0.5% Triton X-100, 2 mM EDTA, 100 mM NaCl, 20 mM Tris·HCl, pH 8.1) and incubated overnight with either anti-ERRα monoclonal antibody (Epitomics), anti-NF-κB (p65) polyclonal antibody (Santa Cruz), or a rabbit IgG antibody as a control (Santa Cruz) and 60 μL of Dynabeads Protein A (Invitrogen 10008D). Beads were washed six times with LiCl buffer (1% Nonidet P-40, 500 mM LiCl, 1% Na-deoxycholate, pH 8.0, 100 mM Tris·HCl, pH 8.1). The beads were next washed briefly with TE buffer (10 mM Tris·HCl, pH 7.5, 1 mM EDTA, pH 8.0) and de-cross-linked (1% SDS, 0.1 M NaHCO3) at 65°C overnight. De-cross-linked samples were purified using the QIAquick Spin Kit (Qiagen).
ChIP samples from murine macrophage cells (Raw 264.7 cells) were prepared with cell culture medium containing formaldehyde (1% final), and DNA-protein cross-linking was allowed to occur at room temperature for 10 min with rotation. The cross-linked cells were washed twice with cold PBS and resuspended in nuclei lysis buffer (50 mM Tris·HCl, pH 8.1, 10 mM EDTA, 1% SDS) supplemented with protease inhibitors (Roche) and subsequently processed as described above for liver ChIP samples. ERRα and NF-κB (p65) standard ChIP enrichments were quantified by qPCR analysis using specific primers and normalized to the average enrichments obtained using two control 
